Re-analysis of whole genome sequencing ends a diagnostic odyssey: Case report of an RNU4-2 related neurodevelopmental disorder.
RNU4‐2
WGS
chromosome 12q
clinical genetics
deep‐phenotyping
dysmorphology
neurodevelopmental disorder
non‐coding genome
Journal
Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664
Informations de publication
Date de publication:
11 Jun 2024
11 Jun 2024
Historique:
revised:
31
05
2024
received:
04
05
2024
accepted:
03
06
2024
medline:
11
6
2024
pubmed:
11
6
2024
entrez:
11
6
2024
Statut:
aheadofprint
Résumé
Despite increasing knowledge of disease-causing genes in human genetics, approximately half of the individuals affected by neurodevelopmental disorders remain genetically undiagnosed. Part of this missing heritability might be caused by genetic variants outside of protein-coding genes, which are not routinely diagnostically investigated. A recent preprint identified de novo variants in the non-coding spliceosomal snRNA gene RNU4-2 as a cause of a frequent novel syndromic neurodevelopmental disorder. Here we mined 164 whole genome sequencing (WGS) trios from individuals with neurodevelopmental or multiple congenital anomaly disorders that received diagnostic genomic investigations at our clinic. We identify a recurrent de novo RNU4-2 variant (NR_003137.2(RNU4-2):n.64_65insT) in a 5-year-old girl with severe global developmental delay, hypotonia, microcephaly, and seizures that likely explains her phenotype, given that extensive previous genetic investigations failed to identify an alternative cause. We present detailed phenotyping of the individual obtained during a 5-year follow-up. This includes photographs showing recognizable facial features for this novel disorder, which might allow prioritizing other currently unexplained affected individuals sharing similar facial features for targeted investigations of RNU4-2. This case illustrates the power of re-analysis to solve previously unexplained cases even when a diagnostic genome remains negative.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : ZonMw
ID : 09150172110002
Pays : Netherlands
Informations de copyright
© 2024 The Author(s). Clinical Genetics published by John Wiley & Sons Ltd.
Références
Perenthaler E, Yousefi S, Niggl E, Barakat TS. Beyond the exome: the non‐coding genome and enhancers in neurodevelopmental disorders and malformations of cortical development. Front Cell Neurosci. 2019;13:352.
Johannesen KM, Tümer Z, Weckhuysen S, Barakat TS, Bayat A. Solving the unsolved genetic epilepsies: current and future perspectives. Epilepsia. 2023;64(12):3143‐3154.
D'Haene E, Vergult S. Interpreting the impact of noncoding structural variation in neurodevelopmental disorders. Genet Med. 2021;23(1):34‐46.
Ostrander BEP, Butterfield RJ, Pedersen BS, et al. Whole‐genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy. NPJ Genom Med. 2018;3:22.
Palmer EE, Sachdev R, Macintosh R, et al. Diagnostic yield of whole genome sequencing after nondiagnostic exome sequencing or gene panel in developmental and epileptic encephalopathies. Neurology. 2021;96(13):e1770‐e1782.
Chen Y, Dawes R, Kim HC, et al. De novo variants in the non‐coding spliceosomal snRNA gene RNU4‐2 are a frequent cause of syndromic neurodevelopmental disorders. medRxiv. 2024. doi:10.1101/2024.04.07.24305438
Dekker J, Schot R, Bongaerts M, et al. Web‐accessible application for identifying pathogenic transcripts with RNA‐seq: increased sensitivity in diagnosis of neurodevelopmental disorders. Am J Hum Genet. 2023;110(2):251‐272.
Cologne A, Benoit‐Pilven C, Besson A, et al. New insights into minor splicing‐a transcriptomic analysis of cells derived from TALS patients. RNA. 2019;25(9):1130‐1149.
Perenthaler E, Nikoncuk A, Yousefi S, et al. Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi‐allelic isoform‐specific start‐loss mutations of essential genes can cause genetic diseases. Acta Neuropathol. 2020;139(3):415‐442.
Deng R, Medico‐Salsench E, Nikoncuk A, et al. AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model. Acta Neuropathol. 2023;146(2):353‐368.
Lesmann H, Hustinx A, Moosa S, et al. GestaltMatcher database ‐ a global reference for the facial phenotypic variability of rare human diseases. medRxiv. 2024. doi:10.1101/2023.06.06.23290887